LobbyingAmerican Association of Neurological Surgeons lobbying by quarter
American Association of Neurological Surgeons's latest lobbying report covers Q2 2026, at $35K. The four quarters Q4 2025–Q3 2026 total $110K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Medicare/Medicaid.
American Association of Neurological Surgeons
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $110K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $35K | 1 |
| Q1 2023 | $45K | 1 |
| Q2 2023 | $35K | 1 |
| Q3 2023 | $45K | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $35K | 1 |
| Q3 2024 | $40K | 1 |
| Q4 2024 | $35K | 1 |
| Q1 2025 | $40K | 1 |
| Q2 2025 | $35K | 1 |
| Q3 2025 | $40K | 1 |
| Q4 2025 | $35K | 1 |
| Q1 2026 | $40K | 1 |
| Q2 2026 | $35K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Budget and appropriations$207.9K · 15 reports
- Medicare and Medicaid$207.9K · 15 reports
- Health issues$150.4K · 12 reports
- Taxation$8,750 · 1 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
- Centers For Medicare and Medicaid Services (CMS)4 reports
- Health & Human Services, Dept of (HHS)4 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseAmerican Association of Neurological Surgeons | $575K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| CHARLOTTE ESTELA PINEDA | US Senate Health, Education, Labor & Pensions (HELP) Committee US Senator Roger Marshall, MD (KS) US Representative Roger Marshall, MD (KS-01) US Representative Chris Collins (NY-27) US Representative Brian Fitzpatrick (PA-08) | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | In-house | $35K |
| 04/14for Q1 | In-house | $40K |
| 01/20for Q4 2025 | In-house | $35K |
| 25/10/20for Q3 2025 | In-house | $40K |
| 25/07/19for Q2 2025 | In-house | $35K |
| 25/04/21for Q1 2025 | In-house | $40K |
| 25/01/21for Q4 2024 | In-house | $35K |
| 24/10/21for Q3 2024 | In-house | $40K |
| 24/07/21for Q2 2024 | In-house | $35K |
| 24/04/16for Q1 2024 | In-house | $40K |
| 24/01/21for Q4 2023 | In-house | $40K |
| 23/10/20for Q3 2023 | In-house | $45K |
| 23/07/20for Q2 2023 | In-house | $35K |
| 23/04/16for Q1 2023 | In-house | $45K |
| 23/01/21for Q4 2022 | In-house | $35K |